Skip to main content
. 2021 Mar 9;14(7):1835–1844. doi: 10.1093/ckj/sfab048

FIGURE 3:

FIGURE 3:

Seroprevalence of anti-SARS-CoV-2 antibodies in HD patients with (A) symptomatic COVID-19 and patients with (B) no previous diagnosis of COVID-19. Values represent the percentage of the whole cohort in each measure.